ASND icon

Ascendis Pharma
ASND

Overview Fund Activity

25 hedge funds and large institutions have $185M invested in Ascendis Pharma in 2015 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 5 closing their positions.

Holders
25
Holders Change
-1
Holders Change %
-3.85%
% of All Funds
0.66%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
4
Increased
7
Reduced
7
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$42.3M
2
RCM
2
RA Capital Management
Massachusetts
$30.6M
3
BBA
3
Baker Bros. Advisors
New York
$9.26M
4
ACP
4
Acuta Capital Partners
California
$9.51M
5
SCM
5
Sio Capital Management
New York
$5.22M

Top Sellers

1
VM
1
VHCP Management
New York
$1.65M
2
GTC
2
Ghost Tree Capital
New York
$0
3
AIC
3
AWM Investment Company
New York
$0
4
Alyeska Investment Group
4
Alyeska Investment Group
Illinois
$0
5
Lazard Asset Management
5
Lazard Asset Management
New York
$3.54M
Name Market Value Shares Shares
Change 		Shares
Change %
AIC
26
AWM Investment Company
New York
– – -78,540 Closed
Alyeska Investment Group
27
Alyeska Investment Group
Illinois
– – -67,079 Closed
PAM
28
Panagora Asset Management
Massachusetts
– – -1,503 Closed
TRCT
29
Tower Research Capital (TRC)
New York
– – -175 Closed
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
$0 6 -36 -86%
1
2